Summary
Definition
History and exam
Other diagnostic factors
- dysphagia
- bloating/early satiety
- laryngitis
- globus
- enamel erosion
- halitosis
- dyspepsia
Risk factors
- family history of heartburn or GORD
- older age
- hiatus hernia
- obesity
- use of lower oesophageal sphincter (LOS) tone-reducing drugs
- psychological stress
- asthma
- use of non-steroidal anti-inflammatory drugs (NSAIDs)
- smoking
- alcohol consumption
- per-oral endoscopic myotomy (POEM)
- dietary factors
- pregnancy
Diagnostic investigations
Investigations to consider
- oesophagogastroduodenoscopy (OGD)
- ambulatory pH monitoring
- oesophageal manometry
- combined impedance-pH testing
- barium swallow
- oesophageal capsule endoscopy
Treatment algorithm
Contributors
Authors
Marc J. Zuckerman, MD
Professor of Medicine
Chief of Division of Gastroenterology
Texas Tech University Health Sciences Center
El Paso
TX
Disclosures
MJZ is on the speakers bureau for Phathom Pharmaceuticals.
Andres F. Carrion, MD
Associate Professor of Clinical Medicine
Division of Gastroenterology and Hepatology
University of Miami
Miami
FL
Disclosures
AFC declares that he has no competing interests.
Acknowledgements
Dr Marc J. Zuckerman and Dr Andres F. Carrion would like to gratefully acknowledge Dr Sheila Feit and Dr Mohamed Othman, previous contributors to this topic.
Disclosures
SF declares that she has no competing interests. MO has acted as a consultant for Olympus.
Peer reviewers
Lars Aabakken, MD
Professor of Medicine
Chief of GI Endoscopy
Rikshospitalet University Hospital
Oslo
Norway
Disclosures
LA declares that he has no competing interests.
Lise Lotte Gluud, MD, DMSc
Consultant
Department of Internal Medicine
Copenhagen University Hospital
Hellerup
Denmark
Disclosures
LLG declares that she has no competing interests.
Gary W. Falk, MD, MS
Professor of Medicine
Department of Gastroenterology & Hepatology
Center for Swallowing & Esophageal Disorders
Cleveland Clinic
Cleveland
OH
Disclosures
GWF has received fees from: AstraZeneca (consultant, speakers bureau, grant support); Takeda (grant support); Pentax (speaker, travel); Wyeth (consultant); and C2 Therapeutics (consultant).
References
Key articles
Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2022 Jan 1;117(1):27-56.Full text Abstract
Muthusamy VR, Lightdale JR, Acosta RD, et al; ASGE Standards of Practice Committee. The role of endoscopy in the management of GERD. Gastrointest Endosc. 2015;81(6):1305-10.Full text Abstract
Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017 Mar;152(4):706-15. Abstract
Ness-Jensen E, Hveem K, El-Serag H, et al. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2016 Feb;14(2):175-82.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available here.
Use of this content is subject to our disclaimer